Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gene Expression Profiling of HBV Vaccination Response
NCT02055365Completed
- Sponsor
- The Rockefeller University
- Start
- Feb 2014
- Primary completion
- Jan 2015
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by The Rockefeller University. Primary endpoints: Number of Differentially Expressed Genes at p < 0.05 at Week 2 and Number of Significantly Differentially Expressed Genes at FDR < 0.05 at Week 2. Started Feb 2014; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02055365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055365.